Suvanza Intangible Assets from 2010 to 2026

SUVZ Stock  USD 0.0002  0.00  0.00%   
Suvanza Pharma Intangible Assets yearly trend continues to be fairly stable with very little volatility. Intangible Assets will likely drop to about 5.2 M in 2026. Intangible Assets is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. View All Fundamentals
 
Intangible Assets  
First Reported
2010-12-31
Previous Quarter
5.5 M
Current Value
5.2 M
Quarterly Volatility
604.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Suvanza Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Suvanza Pharma's main balance sheet or income statement drivers, such as Discontinued Operations of 539.2 K, Interest Expense of 0.0 or Selling General Administrative of 9.9 M, as well as many indicators such as . Suvanza financial statements analysis is a perfect complement when working with Suvanza Pharma Valuation or Volatility modules.
  
Build AI portfolio with Suvanza Stock
Check out the analysis of Suvanza Pharma Correlation against competitors.

Latest Suvanza Pharma's Intangible Assets Growth Pattern

Below is the plot of the Intangible Assets of Suvanza Pharma LLC over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Suvanza Pharma's Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Suvanza Pharma's overall financial position and show how it may be relating to other accounts over time.
Intangible Assets10 Years Trend
Slightly volatile
   Intangible Assets   
       Timeline  

Suvanza Intangible Assets Regression Statistics

Arithmetic Mean6,135,739
Geometric Mean6,111,212
Coefficient Of Variation9.85
Mean Deviation251,207
Median6,095,000
Standard Deviation604,256
Sample Variance365.1B
Range3M
R-Value(0.59)
Mean Square Error255.2B
R-Squared0.34
Significance0.01
Slope(70,260)
Total Sum of Squares5.8T

Suvanza Intangible Assets History

20265.2 M
20255.5 M
20116.1 M
20108.3 M

About Suvanza Pharma Financial Statements

Suvanza Pharma investors use historical fundamental indicators, such as Suvanza Pharma's Intangible Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Suvanza Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Intangible Assets5.5 M5.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Suvanza Stock Analysis

When running Suvanza Pharma's price analysis, check to measure Suvanza Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Suvanza Pharma is operating at the current time. Most of Suvanza Pharma's value examination focuses on studying past and present price action to predict the probability of Suvanza Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Suvanza Pharma's price. Additionally, you may evaluate how the addition of Suvanza Pharma to your portfolios can decrease your overall portfolio volatility.